ondansetron and apraclonidine

ondansetron has been researched along with apraclonidine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Barrett, VJ; Bountra, C; Butler, A; Cambridge, D; Clayton, NM; Gale, J; Humphrey, PP; Hunt, AA; Maxwell, MP; Sargent, R	1

Other Studies

2 other study(ies) available for ondansetron and apraclonidine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat. Neurogastroenterology and motility, 1999, Volume: 11, Issue:3 Topics: Adrenergic alpha-Agonists; Animals; Carbolines; Clonidine; Drug Evaluation, Preclinical; Fasting; Gastrointestinal Transit; Intestine, Small; Ondansetron; Ovalbumin; Radioligand Assay; Rats; Reference Values; Reflex; Serotonin Antagonists; Vagus Nerve	1999

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat.

Neurogastroenterology and motility, 1999, Volume: 11, Issue:3

Topics: Adrenergic alpha-Agonists; Animals; Carbolines; Clonidine; Drug Evaluation, Preclinical; Fasting; Gastrointestinal Transit; Intestine, Small; Ondansetron; Ovalbumin; Radioligand Assay; Rats; Reference Values; Reflex; Serotonin Antagonists; Vagus Nerve

1999